biospecimen__admin__batch_number	399.48.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	8D58F8E8-8BCF-4889-9B15-F65F90E16DD5
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-AAUZ-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-AAUZ-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-G3-AAUZ-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104761
biospecimen__bio__day_of_creation	03
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-G3-AAUZ.09055681-FB0F-4960-86A0-5D6EBD08FAED.pdf
biospecimen__bio__plate_column	10
biospecimen__bio__plate_id	A38M
biospecimen__bio__plate_row	D
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-G3-AAUZ
biospecimen__shared__patient_id	AAUZ
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	816873A6-5FA7-4083-9DD8-32B2B113B6F1
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.3
clinical__chol_lihc_shared__albumin_result_specified_value	3.8
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.3
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.8
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	3
clinical__chol_lihc_shared__fibrosis_ishak_score	1,2 - Portal Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Non-Alcoholic Fatty Liver Disease
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.4
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	48
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-AAUZ-F67244
clinical__clin_shared__bcr_followup_uuid	B54FFF1B-E90C-4B00-AC6A-70B868D99FEF
clinical__clin_shared__day_of_form_completion	14
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	11
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	214
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	HBV Surface Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Severe
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	6f9e29f0-85e3-4762-8845-f835e3576355
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-AAUZ-01A-11R-A38M-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	57b370ae-ca8c-40d0-bbac-ba2c830b7cc3
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.86
gdc__analytes__analyte_id	aa30f6a7-f93b-47fd-9ecd-527b071a2e7a
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	d74ddbe2-5860-40b1-9bd8-99cc50f3392d
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:32:47.609868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	373929fc-fb4a-56ea-8619-a8f87c61fd59
gdc__demographic__ethnicity	hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	not reported
gdc__demographic__year_of_birth	1965
gdc__diagnoses__age_at_diagnosis	17760
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-17760.0
gdc__diagnoses__days_to_last_follow_up	480.0
gdc__diagnoses__diagnosis_id	e9bde52f-fbdf-560b-951f-b8602bdfbed1
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	30.078125
gdc__exposures__exposure_id	b929a7fc-4c3c-537c-bde0-f3e7c8b057f3
gdc__exposures__height	160.0
gdc__exposures__weight	77.0
gdc__file_id	af76b53e-a74b-4615-a8ee-461603835845
gdc__file_name	e48b2770-6f4e-4b3c-9a65-7f9d8a9b6124.mirbase21.mirnas.quantification.txt
gdc__file_size	50255
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	07df8104301640b9bb3ba080bcdf9ccb
gdc__portions__is_ffpe	false
gdc__portions__portion_id	79b2df3c-535c-4841-8047-5b969d723862
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	168
gdc__samples__initial_weight	210.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	09055681-FB0F-4960-86A0-5D6EBD08FAED
gdc__samples__sample_id	7c4e023a-de49-4a4a-b4cf-26731b5650b2
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	2.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	15.0
gdc__slides__percent_tumor_cells	85.0
gdc__slides__percent_tumor_nuclei	85.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	95a936c4-ea1d-4a82-93f8-07df6e710274
gdc__submitter_id	mirna_swap_dr11_150_MirnaExpressionc1eea6d8-3254-45f8-8a57-342aa5346323_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	a51872a0-b5b4-5c3b-8a72-00f7f3c05d1f
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:10.628+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/6f9e29f0-85e3-4762-8845-f835e3576355-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/6f9e29f0-85e3-4762-8845-f835e3576355-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129626
manually_curated__local_md5	c88fc3e30a06a64c6cce73992dcc902d
manually_curated__opengdc_download_date	2018-10-16T17:10:07.000077+02:00
manually_curated__opengdc_file_md5	6f628a79e952cd1adf8ac87c47fee666
manually_curated__opengdc_file_size	50254
manually_curated__opengdc_id	6f9e29f0-85e3-4762-8845-f835e3576355-meq
manually_curated__origin_file_size	129626
manually_curated__origin_last_modified_date	Tue Oct 16 17:37:00 CEST 2018
manually_curated__origin_md5	c88fc3e30a06a64c6cce73992dcc902d
manually_curated__tissue_status	tumoral
